TA-65: A Revolutionary Health Supplement Enhancing Immunity and Mitigating Inflammation in Heart Attack Patients
Newcastle, UK (PRWEB) June 21, 2023 -- A groundbreaking study led by Professor Ioakim Spyridopoulos of Newcastle University showcases the promising potential of TA-65®, a dietary supplement, in improving patient outcomes after a heart attack.
The research, conducted in collaboration with the heart team at The James Cook University Hospital in Middlesbrough, focused on the role of TA-65® in combating immunosenescence — the aging of the immune system — and reducing inflammation, a critical factor in heart attack and subsequent complications.
Reducing inflammation is a key treatment target following a heart attack. Remarkably, the study, published in GeroScience, revealed that TA-65® not only significantly reduced inflammation by up to 62%, but also increased the number of immune cells, enhancing the immunity of patients.
Highlighting the distinctness of TA-65®, Spyridopoulos stated, "Unlike most potent anti-inflammatory drugs that suppress the immune system and increase the risk of severe infections, the widely available health supplement TA-65® appears to reduce inflammation while concurrently improving immunity."
Furthermore, TA-65® has shown potential benefits for mitochondrial health, contributing to the overall vitality and wellness of individuals, particularly those recovering from myocardial infarction. As the 'powerhouses' of cells, healthy mitochondria play a crucial role in the body's overall health and resilience, which makes the benefits of TA-65 in this area particularly promising.
"TA-65's demonstrated safety profile and significant health benefits make it a valuable new addition to the toolkit for managing the common issue of immunosenescence following a heart attack," said Spyridopoulos.
TA-65® is widely accessible to those who can benefit from its health-enhancing properties and is available for purchase through T.A. Sciences® on their website http://www.tasciences.com, as well as through healthcare professionals.
About Newcastle University:
Newcastle University is a world-leading institution committed to research excellence, impacting global challenges and offering a high-quality student experience.
About The James Cook University Hospital:
The James Cook University Hospital is a leading provider of cardiovascular care serving over 1.5 million people with a reputation for continually improving treatment options for patients.
About T.A. Sciences®:
T.A. Sciences® is a biotech firm exclusively dedicated to the development of research-based, clinically tested wellness products that help address telomere shortening through Telomerase Activation. Built on a scientifically grounded foundation, T.A. Sciences® is a recognized leader in the field of Telomere Biology, investing in cutting-edge scientific research, including double-blind, placebo-controlled studies that validate the safety and effectiveness of its flagship product.
For more information about T.A. Sciences® and its groundbreaking products, please contact:
Phone: 1-888-360-8886
Website: https://www.tasciences.com/
Note to editors:
High-resolution images and interviews are available upon request. For more information, please contact Sebastian Conti at [email protected] or 212.588.8805.
Sebastian Conti, T.A. Sciences, http://www.tasciences.com, 1 212.588.8805, [email protected]
Share this article